Immunogenicity profile of a 3.75-Ug hemagglutinin pandemic rH5N1 split virion As03A-adjuvanted vaccine in elderly persons : a randomized trial

Stephane Heijmans,1 Marc De Meulemeester,1 Paul Reynders,1, Didier Giet,1 Etienne Demanet,1 Pierre-Yves Devresse,1 Giancarlo Icardi,3 Mamadou Drame,2 Franc xois Roman,2 and Paul Gillard2 1ResearchLink, Department Clinical Trial Network, Linkebeek, FlemishBrabant, 2GlaxoSmithKline Biologicals, Wavre, Walloon Brabant, Belgium; 3Department of Health Sciences and San Martino Teaching Hospital, University of Genoa, Genoa, Italy